Title:
Ｐ２Ｘ７受容体拮抗薬としてのテトラヒドロキノリン誘導体
Document Type and Number:
Japanese Patent JP6823196
Kind Code:
B2
Abstract:
The present invention relates to tetrahydroquinoline derivatives of the present invention or a pharmaceutically acceptable salt thereof or a prodrug thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the P2X7 receptor.
Inventors:
Hirohide Noguchi
Yoshino Shinno
Kazuo Ando
Kazuki Toyoshima
Toshihiko Sone
Hiroki Matsubara
Yoshino Shinno
Kazuo Ando
Kazuki Toyoshima
Toshihiko Sone
Hiroki Matsubara
Application Number:
JP2019550864A
Publication Date:
January 27, 2021
Filing Date:
March 13, 2018
Export Citation:
Assignee:
RaQualia Pharma Co., Ltd.
Asahi Kasei Pharma Co., Ltd.
Asahi Kasei Pharma Co., Ltd.
International Classes:
C07D215/48; A61K31/435; A61K31/47; A61K31/4709; A61K31/4747; A61K31/5377; A61K31/5386; A61K45/00; A61P1/00; A61P3/00; A61P9/00; A61P13/12; A61P15/00; A61P17/00; A61P19/00; A61P25/00; A61P27/06; A61P29/00; A61P31/06; A61P35/00; A61P37/02; A61P43/00; C07D221/04; C07D401/06; C07D401/12; C07D405/06; C07D405/12; C07D413/12; C07D417/12; C07D417/14; C07D498/10
Foreign References:
| WO2004106305A1 | ||||
| WO2005009968A1 | ||||
| WO2015187905A1 | ||||
| WO2014097140A1 | ||||
| WO2008124153A1 |
Attorney, Agent or Firm:
Ryu Iwatani